On August 5, 2020 Exicure, Inc. (NASDAQ:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) technology, reported that David Giljohann, CEO, will present a Fireside Chat at the BTIG Virtual Biotechnology Conference 2020 on Monday, August 10, 2020 (Press release, Exicure, AUG 5, 2020, View Source [SID1234562951]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Monday, August 10, 2020
Time: 1:30 PM Eastern Time
Location: Virtual Webcast

The presentation will be available for live streaming via View Source and will also be available on BTIG’s conference portal.

Replays of the webcast will be available on Exicure’s website for 30 days following the webcast.